comparemela.com

Latest Breaking News On - Jefferies india private - Page 7 : comparemela.com

Concord Biotech makes a healthy debut on the exchange, shares close 27% premium over the issue price

Concord Biotech makes a healthy debut on the exchange, shares close 27% premium over the issue price
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Singapore
Ecuador
Nepal
Thailand
United-states
Japan
Indonesia
India
Kenya
Mexico
Paraguay

Fermentation based API Major, Concord Biotech IPO sees 24.86 times subscription on Day 3

Fermentation based API Major, Concord Biotech IPO sees 24.86 times subscription on Day 3
freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.

India
Ecuador
Paraguay
Mexico
Thailand
Nepal
Japan
Indonesia
Kenya
Singapore
United-states

IPO screener: Jhunjhunwala-backed Concord Biotech issue closes today

IPO screener: Jhunjhunwala-backed Concord Biotech issue closes today
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Ahmedabad
Gujarat
India
Singapore
Abu-dhabi
Abuz-aby
United-arab-emirates
Japan
Nippon
Aditya-birla-sun
Concord-biotech
Jefferies-india-private

IPO screener: Jhunjhunwala-backed Concord Biotech subscribed 0.6 times on Day 1

IPO screener: Jhunjhunwala-backed Concord Biotech subscribed 0.6 times on Day 1
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Ahmedabad
Gujarat
India
Singapore
Japan
Abu-dhabi
Abuz-aby
United-arab-emirates
Nippon
Aditya-birla-sun
Jefferies-india-private
Mutual-fund

vimarsana © 2020. All Rights Reserved.